Europeans do not benefit from an equal access to cancer treatment, according to a report published on Friday (16 January) by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The research by Nils Wilking, clinical oncologist at the Karolinska Institutet in Stockholm, and Bengt Jonsson, professor of health economics at the Stockholm School of Economics, covers all EU states but Cyprus and Malta, as well as Iceland, Norway and Switzerland.
It also shows...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? Login